Thank you, Matt. Welcome to the Aemetis’s First Quarter 2023 Earnings Review Conference Call. Joining us for the call today is Eric McAfee, Founder, Chairman and CEO of Aemetis; and Andy Foster, President of Aemetis Advanced Fuels and Aemetis Biogas. We suggest visiting our website at aemetis.com to review today’s earnings press release, the Aemetis Corporate and Investor Presentations, filings with the Securities and Exchange Commission, recent press releases and previous earnings conference calls. The presentation for today’s call is available for review or download on the Investors section of aemetis.com website. Before we begin our discussion today, I’d like to read the following disclaimer statement. During today’s call, we will be making forward-looking statements, including, without limitation, statements with respect to our future stock performance, plans, opportunities and expectations with respect to financing activities and the execution of our business plan. These statements must be considered in conjunction with the disclosures and cautionary warnings that appear in our SEC filings. Investors are cautioned that all forward-looking statements made on this call involve risks and uncertainties and that future events may differ materially from the statements made. For additional information, please refer to the company’s Securities and Exchange Commission filings, which are posted on our website and available from the company without charge. Our discussion on this call will include a review of non-GAAP measures as a supplement to financial results based on GAAP because we believe these non-GAAP measures serve as a proxy for the company’s source or use of cash during the periods presented. A reconciliation of the non-GAAP measures to the most directly comparable GAAP measures is included in our earnings release for the 3 months ended on March 31, 2023, which is available on our website. Adjusted EBITDA is defined as net income or loss plus to the extent deducted in calculating such net income, interest expense, loss or gain on debt extinguishment, income tax expense, intangible and other amortization expense, accretion and other expenses of Series A preferred units, loss on lease termination, certain cash grants, gain on litigation, depreciation expense and share-based compensation expense. Now let’s review the financial results for the first quarter of 2023. Revenue during the first quarter of 2023 decreased to $2.2 million compared to $52.0 million for the first quarter of 2022. Due to historically high natural gas prices in December 22, we made the decision to idle the Keyes plant in our North America division and initiated an extended maintenance cycle, which extended through the end of the first quarter, allowing for acceleration of several important ethanol plant energy efficiency upgrades. Working on the extensive plant maintenance and upgrade during Q1 of 2023 enabled the Keyes plant to avoid significant loss due to insufficient natural gas storage in the Western United States that made continuing operations uneconomical. From December through March, exorbitant pricing for natural gas would have resulted in a significant loss for the ethanol business. So management made the difficult but necessary decision to temporarily idle production. The Dairy Natural Gas segment produced 21,300 MMBtus from six dairy digesters and the RNG was placed in underground storage to preserve carbon credits while waiting for approval of a low carbon fuel standard pathway for each digester. At an expected approval CI value of minus 427, this inventory represents meaningful future revenue that will be recognized once the pathways are approved. India Biodiesel recognized $1.5 million of revenue from private customers. Gross loss for the first quarter of 2023 was $1.3 million compared to a $3.1 million loss during the first quarter of 2022. Selling, general and administrative expense increased to $10.8 million during the first quarter of 2023 from $7.3 million during the same period in 2022, driven primarily by a $2.7 million of fixed cost of goods sold, charged to selling, general and administrative expense during the idle time. Operating loss was $12.1 million for the first quarter of 2023 compared to operating loss of $10.4 million for the same period in 2022. Interest expense excluding accretion of Series A preferred units in the Aemetis Biogas LLC subsidiary increased to $9 million during the first quarter of 2023 compared to $6.3 million during the first quarter of 2022. Additionally, our Aemetis Biogas initiative recognized $5.6 million of accretion of preferred payment during the first quarter of 2023 compared to $1.6 million during the first quarter of 2022. Net loss was $26.4 million for the first quarter of 2023 compared to net loss of $18.3 million for the first quarter of 2022. Cash at the end of the first quarter of 2023 was $4.1 million compared to $4.3 million at the close of the fourth quarter of 2022. Investments in capital projects related to the reduction of the carbon intensity of Aemetis ethanol were $7.6 million for the first quarter of 2023. This completes our review of the first quarter of 2023. Now I’d like to introduce the Founder, Chairman and Chief Executive Officer of Aemetis, Eric McAfee, for a business update. Eric?